ALEXANDRA HARLAN: Open Payments
NPI 1972299931 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 36 payments from 11 companies in 2025. Trend: 2023 $839 · 2024 $780 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $250 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Alkermes, Inc. | 5 | $109 |
| Vanda Pharmaceuticals Inc. | 5 | $100 |
| ABBVIE INC. | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Noven Therapeutics, LLC | 1 | $17 |
Products named: Auvelity, COBENFY, VRAYLAR, TRINTELLIX, ARISTADA, REXULTI, HETLIOZ, SPRAVATO.
Industry payments across TN — which companies pay providers there.
